MENU
BEAM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Beam Therapeutics (BEAM) Ownership - Who owns Beam Therapeutics?
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases... Show more
Profile
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.04B
P/E Ratio
N/A
Total Cash
850.74M
Projected Growth
N/A
Total Debt
161.43M
Revenue
63.52M
Risk (Beta)
2.46
Dividend Yield
N/A
Total Cash/Share
8.46
Total Debt/Equity
N/A
Revenue/Share
0.77 USD as % of share price
Fundamentals
BEAM
Capitalization
2.04B
P/E Ratio
N/A
Risk (Beta)
2.46
Dividend Yield
N/A
Total Cash
851M
Total Cash/Share
8.46
Total Debt
161M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.77%
Revenue
63.5M
ROE
N/A
Book Value
734M
P/B Ratio
2.77
Cash Flow
N/A
Earnings
-4.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
836K
Current Ratio
4.82
Current Revenue Per Employee
62250.52
Dividends Per Share - Security
N/A
EBITDA
-383.98M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.39
Shares Held By Institutions
3.87B
Shares Outstanding - Current
101M
Total Liabilities
370M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.387
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com